ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1835

Diagnosis of Fibromyalgia: Disagreement between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic

Sachin Srinivasan1, Juan Schmukler2, Shakeel Jamal3, Isabel Castrejón2, Kathryn A Gibson4, Winfried Häuser5, Theodore Pincus2 and Frederick Wolfe6, 1Internal Medicine, University of Kansas School of Medicine, Wichita, KS, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL, 3Rheumatology, Rush University, Chicago, IL, 4Ingham Institute, Liverpool Hospital University of New South Wales, Liverpool, Australia, 5Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, 6FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Diagnostic criteria and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M082 ACR Abstract: Fibromyalgia & Other Clinical Pain Syndromes (1834–1839)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Recent studies have suggested that fibromyalgia is inaccurately diagnosed in the community, and that approximately 75% of persons reporting a physician diagnosis of fibromyalgia would not satisfy published criteria. To investigate possible misclassification, we studied fibromyalgia diagnosis by comparing expert physician diagnosis with published criteria.

Methods: In a university rheumatology clinic, 497 consecutive unselected patients completed the Multi-dimensional Health Assessment Questionnaire (MDHAQ) as well as the 2010 American College of Rheumatology (ACR) preliminary diagnostic criteria for fibromyalgia questionnaire (FCQ) modified for self-administration during their ordinary medical visit. Patents were evaluated and diagnosed by university rheumatology staff who did not review the FCQ.

Results: Of the 497 patients, 121 (24.3%) satisfied fibromyalgia criteria while 104 (20.9%) received a clinician ICD diagnosis of fibromyalgia. The overall agreement between clinicians and criteria was 79.2%. However, agreement beyond chance was only fair: kappa 0.41 [probabilistic category 0.20 -0.40]. Physicians failed to identify 60 (49.6%) of criteria positive patients and incorrectly identified 43 (11.4%) of criteria negative patients as shown in Figure 1.

:::statdata:rushfm:fmmisclass.png

As shown in Figure 2, clinician diagnosed case varied widely in PSD scores, while criteria positive cases and criteria and clinician negative cases had appropriate PSD scores.

:::statdata:rushfm:tridensity.png

Because there were approximately 4 times as many clinical fibromyalgia negative patients, the total counts of positive and negative misclassifications (60 vs. 43) were closer than the percentages suggested. In a subset of 88 patients with rheumatoid arthritis, the kappa statistic was 0.32, indicating slight to fair agreement [0.00-0.20].  Universally, higher PSD scores and criteria based diagnosis were associated with more abnormal MDHAQ clinical scores. Women, patients with more symptoms but fewer pain areas, and those with lower polysymptomatic distress (PSD scores were more likely to receive a clinicianÕs diagnosis than to satisfy fibromyalgia criteria.

Conclusion: There is considerable disagreement between clinical diagnosis as recorded in ICD codes and criteria determined diagnosis of fibromyalgia, confirming diagnostic problems found in the community and calling into question ICD based fibromyalgia studies. Fibromyalgia criteria were easy to use, but problems regarding clinician bias, meaning of a fibromyalgia diagnosis, and the validity of physician diagnosis were substantial.


Disclosure: S. Srinivasan, None; J. Schmukler, None; S. Jamal, None; I. Castrejón, None; K. A. Gibson, None; W. Häuser, None; T. Pincus, None; F. Wolfe, None.

To cite this abstract in AMA style:

Srinivasan S, Schmukler J, Jamal S, Castrejón I, Gibson KA, Häuser W, Pincus T, Wolfe F. Diagnosis of Fibromyalgia: Disagreement between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/diagnosis-of-fibromyalgia-disagreement-between-fibromyalgia-criteria-and-clinician-based-fibromyalgia-diagnosis-in-a-university-clinic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnosis-of-fibromyalgia-disagreement-between-fibromyalgia-criteria-and-clinician-based-fibromyalgia-diagnosis-in-a-university-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology